Linical Co Ltd
TSE:2183

Watchlist Manager
Linical Co Ltd Logo
Linical Co Ltd
TSE:2183
Watchlist
Price: 318 JPY
Market Cap: ¥7.9B

Operating Margin

-9.1%
Current
Declining
by 12.2%
vs 3-y average of 3.1%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-9.1%
=
Operating Income
¥-901.9m
/
Revenue
¥9.9B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-9.1%
=
Operating Income
¥-901.9m
/
Revenue
¥9.9B

Peer Comparison

Country Company Market Cap Operating
Margin
JP
Linical Co Ltd
TSE:2183
7.2B JPY
Loading...
US
PerkinElmer Inc
LSE:0KHE
1.3T USD
Loading...
US
Thermo Fisher Scientific Inc
NYSE:TMO
241.5B USD
Loading...
US
Danaher Corp
NYSE:DHR
169.6B USD
Loading...
KR
Samsung Biologics Co Ltd
KRX:207940
83.2T KRW
Loading...
CH
Lonza Group AG
SIX:LONN
38.1B CHF
Loading...
US
IQVIA Holdings Inc
NYSE:IQV
40.7B USD
Loading...
CN
WuXi AppTec Co Ltd
SSE:603259
280.3B CNY
Loading...
US
Agilent Technologies Inc
NYSE:A
39.3B USD
Loading...
US
Mettler-Toledo International Inc
NYSE:MTD
29.4B USD
Loading...
FR
Sartorius Stedim Biotech SA
PAR:DIM
20.4B EUR
Loading...

Market Distribution

Lower than 95% of companies in Japan
Percentile
5th
Based on 6 730 companies
5th percentile
-9.1%
Low
-125 500% — 4.2%
Typical Range
4.2% — 10.6%
High
10.6% — 9 743.7%
Distribution Statistics
Japan
Min -125 500%
30th Percentile 4.2%
Median 7%
70th Percentile 10.6%
Max 9 743.7%

Linical Co Ltd
Glance View

Linical Co., Ltd. engages in pharmaceutical contract research projects providing consulting, monitoring, and quality control services to pharmaceutical companies. The company is headquartered in Osaka, Osaka-Fu and currently employs 845 full-time employees. The company went IPO on 2008-10-27. The firm operates in two businesses. The CRO segment is engaged in the provision of contract monitoring, quality management and consulting services for phase II and phase III in drug development processes. The Pharmaceutical Sales Support segment is engaged in provision of pharmaceutical sales support for medical institutions in the downstream market.

Intrinsic Value
595.2 JPY
Undervaluation 47%
Intrinsic Value
Price
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-9.1%
=
Operating Income
¥-901.9m
/
Revenue
¥9.9B
What is Linical Co Ltd's current Operating Margin?

The current Operating Margin for Linical Co Ltd is -9.1%, which is below its 3-year median of 3.1%.

How has Operating Margin changed over time?

Over the last 3 years, Linical Co Ltd’s Operating Margin has decreased from 8% to -9.1%. During this period, it reached a low of -9.1% on Oct 30, 2025 and a high of 11% on Jun 30, 2023.

Back to Top